Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy

Objectives: To assess the clinical outcomes of prostate cancer patients treated with salvage radiotherapy (SRT) for locoregional clinical recurrence (CR) after radical prostatectomy (RP). Methods: Records of 60 patients with macroscopic locoregional recurrence after prostatectomy and referrals for S...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sung Uk Lee MD, Kwan Ho Cho MD, Jin Ho Kim MD, Young Seok Kim MD, Taek-Keun Nam MD, Jae-Sung Kim MD, Jaeho Cho MD, Seo Hee Choi MD, Su Jung Shim MD, Jin Hee Kim MD, Ah Ram Chang MD
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/802cb9337c2c4010bb15c0453bb9e04e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:802cb9337c2c4010bb15c0453bb9e04e
record_format dspace
spelling oai:doaj.org-article:802cb9337c2c4010bb15c0453bb9e04e2021-11-21T02:04:41ZClinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy1533-033810.1177/15330338211041212https://doaj.org/article/802cb9337c2c4010bb15c0453bb9e04e2021-11-01T00:00:00Zhttps://doi.org/10.1177/15330338211041212https://doaj.org/toc/1533-0338Objectives: To assess the clinical outcomes of prostate cancer patients treated with salvage radiotherapy (SRT) for locoregional clinical recurrence (CR) after radical prostatectomy (RP). Methods: Records of 60 patients with macroscopic locoregional recurrence after prostatectomy and referrals for SRT were retrospectively investigated in the multi-institutional database. The median radiation dose was 70.2 Gy. Biochemical failure was defined as the prostate-specific antigen (PSA) ≥ nadir + 2 or initiation of androgen deprivation therapy (ADT) for increased PSA. Results: Median recurrent tumor size was 1.1 cm and pre-radiotherapy PSA level was 0.4 ng/ml. At a median follow-up of 83.1-month after SRT, 7-year biochemical failure-free survival (BCFFS), locoregional failure-free survival (LRFFS), distant metastasis-free survival (DMFS), and overall survival (OS) were 67.0%, 89.7%, 83.6%, and 91.2%, respectively. Higher Gleason's scores were associated with unfavorable BCFFS, DMFS, and OS. Pre-SRT PSA ≥0.5 ng/ml predicted worse BCFFS, LRFFS, and DMFS. In multivariate analyses, a Gleason's score of 8 to 10 was associated with decreased BCFFS (hazard ratio [HR] 3.12, 95% confidence interval [CI] 1.11-8.74, P  = .031) and OS (HR 17.72, 95% CI 1.75-179.64, P  = .015), and combined ADT decreased the risks of distant metastasis (HR 0.18, 95% CI 0.04-0.92, P  = .039). Two patients (3.3%) experienced late grade 3 urinary toxicity. Conclusions: SRT for locoregional CR after RP achieved favorable outcomes with acceptable long-term toxicities. Higher Gleason's scores and pre-radiotherapy PSA level were unfavorable prognostic variables. Combined ADT may decrease the risks of metastases.Sung Uk Lee MDKwan Ho Cho MDJin Ho Kim MDYoung Seok Kim MDTaek-Keun Nam MDJae-Sung Kim MDJaeho Cho MDSeo Hee Choi MDSu Jung Shim MDJin Hee Kim MDAh Ram Chang MDSAGE PublishingarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENTechnology in Cancer Research & Treatment, Vol 20 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Sung Uk Lee MD
Kwan Ho Cho MD
Jin Ho Kim MD
Young Seok Kim MD
Taek-Keun Nam MD
Jae-Sung Kim MD
Jaeho Cho MD
Seo Hee Choi MD
Su Jung Shim MD
Jin Hee Kim MD
Ah Ram Chang MD
Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy
description Objectives: To assess the clinical outcomes of prostate cancer patients treated with salvage radiotherapy (SRT) for locoregional clinical recurrence (CR) after radical prostatectomy (RP). Methods: Records of 60 patients with macroscopic locoregional recurrence after prostatectomy and referrals for SRT were retrospectively investigated in the multi-institutional database. The median radiation dose was 70.2 Gy. Biochemical failure was defined as the prostate-specific antigen (PSA) ≥ nadir + 2 or initiation of androgen deprivation therapy (ADT) for increased PSA. Results: Median recurrent tumor size was 1.1 cm and pre-radiotherapy PSA level was 0.4 ng/ml. At a median follow-up of 83.1-month after SRT, 7-year biochemical failure-free survival (BCFFS), locoregional failure-free survival (LRFFS), distant metastasis-free survival (DMFS), and overall survival (OS) were 67.0%, 89.7%, 83.6%, and 91.2%, respectively. Higher Gleason's scores were associated with unfavorable BCFFS, DMFS, and OS. Pre-SRT PSA ≥0.5 ng/ml predicted worse BCFFS, LRFFS, and DMFS. In multivariate analyses, a Gleason's score of 8 to 10 was associated with decreased BCFFS (hazard ratio [HR] 3.12, 95% confidence interval [CI] 1.11-8.74, P  = .031) and OS (HR 17.72, 95% CI 1.75-179.64, P  = .015), and combined ADT decreased the risks of distant metastasis (HR 0.18, 95% CI 0.04-0.92, P  = .039). Two patients (3.3%) experienced late grade 3 urinary toxicity. Conclusions: SRT for locoregional CR after RP achieved favorable outcomes with acceptable long-term toxicities. Higher Gleason's scores and pre-radiotherapy PSA level were unfavorable prognostic variables. Combined ADT may decrease the risks of metastases.
format article
author Sung Uk Lee MD
Kwan Ho Cho MD
Jin Ho Kim MD
Young Seok Kim MD
Taek-Keun Nam MD
Jae-Sung Kim MD
Jaeho Cho MD
Seo Hee Choi MD
Su Jung Shim MD
Jin Hee Kim MD
Ah Ram Chang MD
author_facet Sung Uk Lee MD
Kwan Ho Cho MD
Jin Ho Kim MD
Young Seok Kim MD
Taek-Keun Nam MD
Jae-Sung Kim MD
Jaeho Cho MD
Seo Hee Choi MD
Su Jung Shim MD
Jin Hee Kim MD
Ah Ram Chang MD
author_sort Sung Uk Lee MD
title Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy
title_short Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy
title_full Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy
title_fullStr Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy
title_full_unstemmed Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy
title_sort clinical outcome of salvage radiotherapy for locoregional clinical recurrence after radical prostatectomy
publisher SAGE Publishing
publishDate 2021
url https://doaj.org/article/802cb9337c2c4010bb15c0453bb9e04e
work_keys_str_mv AT sungukleemd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy
AT kwanhochomd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy
AT jinhokimmd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy
AT youngseokkimmd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy
AT taekkeunnammd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy
AT jaesungkimmd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy
AT jaehochomd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy
AT seoheechoimd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy
AT sujungshimmd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy
AT jinheekimmd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy
AT ahramchangmd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy
_version_ 1718419374518304768